Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity ...

U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical subsidiary Tanabe Mitsubishi Pharma to U.S. private ...

Mitsubishi Electric Corporation (TOKYO: 6503) announced today that the international nonprofit CDP has once again given ...

TOKYO -- Japan's Mitsubishi Chemical Group announced on Friday the agreed sale of its pharmaceutical subsidiary, Mitsubishi Tanabe Pharma, to U.S. investment fund Bain Capital for approximately 510 ...

TOKYO: Japan's Mitsubishi Corp took a ¥66.8 billion (US$438.61 million) impairment charge on its domestic offshore wind ...

Japan's Mitsubishi Corp posted on Thursday a 19% increase in nine-month net profit to December to 827.4 billion yen ($5.43 ...

Mitsubishi Corp on Monday said it is reviewing how to proceed with its offshore wind projects in Japan given a "significantly ...

Profit rose in the nine-month period from April to December 2024 for Japanese conglomerate Mitsubishi compared tot he same ...

Japanese conglomerate Mitsubishi Corp. (MBC.L, MSBHY.PK) reported Thursday that its profit attributable to owners of the parent for ...

Couldn't resolve component "default" at "/:pathMatch (.*)?/:lcsId ( [0-9]\- [0-9]\- [0-9]+| [0-9]- [0-9]- [0-9]+PT [0-9]+)" ...

Bain Capital has agreed to acquire Tanabe Pharma, the pharma arm of Mitsubishi Chemical Group Corporation. The deal puts Tanabe Pharma at a valuation of about $3.3 billion. Founded in 1678, Tanabe ...